Furthermore, a recent study demonstrated that promoter methylation status of another protocadherin (PCDH20) was also associated with a shorter OS in lung cancer 31; therefore, the role of other protocadherin methylation in NSCLC needs to be investigated in future studies. The gene discussed is PCDH20; the disease is lung carcinoma.